Specially designed Course for Freshers and entry Level Professionals on Clinical Data Management is going to be held 29 Nov (Sunday) from 10:00 A.M-12:30...
November 20, 2020: "AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for an additional dosing option, a 1,500mg fixed dose every four weeks, in the...
November 19, 2020: "Novartis announced today that it entered into an exclusive worldwide license and collaboration agreement with Mesoblast to develop, commercialize and manufacture remestemcel-L...
November 20, 2020: "Sosei Group Corporation announces a progress update for its R&D program focused on the design and development of novel drugs targeting...
November 18, 2020: "ViiV Healthcare, with Pfizer Inc. and Shionogi Limited as shareholders announced positive initial findings from the PROgress study, which was...
November 18, 2020: "Pfizer and BioNTech announced that, after conducting the final efficacy analysis in their ongoing Phase 3 study, their mRNA-based COVID-19 vaccine...
November 16, 2020: Lead Pharma, a clinical stage pharmaceutical company, designing and developing innovative medicines for the treatment of immune mediated diseases and cancer...
November 18, 2020: "The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to the oral investigational Bruton’s tyrosine kinase (BTK) inhibitor,...
November 16, 2020: "The Department for Health and Social Care Testing Innovation Fund has backed the Wellcome Sanger Institute and the COVID-19 Genomics UK...
November 12Â 2020: The University of Exeter and Medicines Discovery Catapult (MDC) announce their strategic partnership to accelerate medicines Research & Development (R&D), creating value...